SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
SEC Accession No. 0001193125-24-083560
Filing Date
2024-04-01
Accepted
2024-04-01 17:00:49
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-01

Document Format Files

Seq Description Document Type Size
1 NT 10-K d821503dnt10k.htm NT 10-K 26795
  Complete submission text file 0001193125-24-083560.txt   27939
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: NT 10-K | Act: 34 | File No.: 001-36183 | Film No.: 24810617
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)